期刊文献+

深圳地区女性生殖道HPV感染及基因型结果分析 被引量:5

Analysis of women′s genital human papillomavirus infection and genotype distribution in Shenzhen
下载PDF
导出
摘要 目的:研究深圳市宝安区女性人乳头瘤病毒(HPV)感染情况,以及不同年龄段 HPV 阳性率和各亚型的分布情况。方法采用聚合酶链式反应-反向斑点杂交法(PCR-RDB)对2011年1月至2012年12月在深圳市宝安区妇幼保健院就诊的患者(2627例)进行23种 HPV 基因分型检测。结果2627例样本中 HPV 阳性率为23.94%(629例)。其中单一低危型感染占15.10%,以 HPV43型为主;单一高危型感染占55.17%,以 HPV52、HPV16、HPV58型为主;混合感染占29.73%。15~<21岁、21~<31岁、31~<41岁、41~50岁与>50岁年龄组 HPV 感染率分别为50.0%、24.7%、20.8%、25.8%、42.1%,差异有统计学意义(P <0.05)。结论深圳市宝安地区 HPV 感染率为23.94%,基因型分布以 HPV 52、16、58、43型为主,15~20岁年龄段感染率高于其他年龄段。 Objective To investigate the female human papillomavirus(HPV)infection situation in Baoan district,the HPV pos-itive rates in different age groups and the subtypes distribution.Methods PCR followed with reverse dot blot was performed to ex-amine 23 kinds of HPV genotypes in 2 627 female patients in our hospital from the January 2011 to December 2012.Results In 2 627 samples,the positive rate of HPV was 23.94% (629 cases),in which the infection rate of single low-risk type was 15.1%(95 cases),the main HPV genotype was HPV43 (7.79%);the infection rate of high-risk type was 55.17% (347 cases),the 3 most prevalent HPV genotypes were HPV52 (12.56%),HPV16 (9.86%)and HPV58 (7.79%).The multiple HPV infection ac-counted for 29.73% (187 cases).The HPV infection rates in different age groups were 50.0% in age 15-20 years,24.7% in age 21-30 years,20.8% in age 31-40 years,25.8% in age 41 -50 years,42.1% in age >50 years respectively,the differences had statistical significance.Conclusion The HPV infection rate is 23.94% in Bao′an district.The most prevalent HPV genotypes are HPV 52,16,58,43.Women in age 15-20 years old have a higher infection rate.
出处 《国际检验医学杂志》 CAS 2014年第14期1878-1879,共2页 International Journal of Laboratory Medicine
关键词 人乳头瘤病毒 基因分型 聚合酶链式反应 反向斑点杂交 HPV genotype PCR reverse dot blot hybridization
  • 相关文献

参考文献9

  • 1Halfon P,IAndemann ML,Raimondo A, et al. HPV genotype dis- tribution according to severity of cervical ncopiasia using the Di- gene HPV genotyping LQ test[J]. Arch Viral, 2013, 158 (6) : 1143 -1149.
  • 2Giuliano AR,Siegel EM, Roe DJ, et al. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig- McGill HPV Natural History Study[J]. J Infect Dis, 2003, 188 (10) : 1508-1516.
  • 3吴夏枫,喻晶,刘晓翌,张银汉.1000例妇女宫颈人乳头瘤病毒基因分型检测结果分析[J].中国实验诊断学,2013,17(5):865-867. 被引量:27
  • 4廖兵,张双庆,魏祥松.某地区妇女HPV感染情况及基因型的分布[J].国际检验医学杂志,2011,32(4):498-499. 被引量:15
  • 5Garcia-Espinosa B, Moro-P, odriguez E. Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Ma- drid, Spain[J]. BMC Cancer, 2012,12 : 533.
  • 6Peng RR, Li HM, Chang H, et al. Prevalence and genotype distri- bution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis[J]. Sex Health,2012,9(2) :113-119.
  • 7Bao YP, Li N, Smith JS, et al. Human papillomavirus type-distri- bution in the cervix of Chinese women: a meta analysis[J]. Int J STD AIDS,2008,19(2) : 106- 111.
  • 8唐玉芬,聂俊玮,黄梅霞.茂名地区妇女生殖道HPV感染及其亚型分布情况分析[J].国际检验医学杂志,2013,34(3):327-328. 被引量:12
  • 9冯玉华,余世宁.珠海市斗门区育龄妇女宫颈HPV病毒感染因素及亚型分布情况调查[J].中国现代医药杂志,2013,15(3):59-60. 被引量:3

二级参考文献33

共引文献52

同被引文献49

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2Kroupis C,Vourlidis N.Human papilloma virus(HPV)molecular diagnostics[J].Clin Chem Lab Med,2011,49(11):1783-1799.
  • 3Honegger A,Leitz J,Bulkescher J,et al.Silencing of human papillomavirus(HPV)E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells[J].Int J Cancer,2013,133(7):1631-1642.
  • 4Peng RR,Li HM,Chang H,et al.Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia:a systematic literature review and meta-analysis[J].Sex Health,2012,9(2):113-119.
  • 5Lee SA,Kang D,Seo SS,et al.Multiple HPV infection in cervical cancer screened by HPV DNA chip[J].Cancer Lett,2003,198(2):187-192.
  • 6Halfon P, Benmoura D, Khiri HA, et al. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck (R) HPV-screening assay[J]. J Clin Virol,2010,47(1) :38-42.
  • 7Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:an interim analysis of a phase Ⅲ double-blind, randomised controlledtrial[J].Lancet, 2007,369(9580) :2161-2170.
  • 8Woodman CB, Cotlins S, Winter H, et al. Natural history of cervicalhuman papillomavirus infection in young women: a longitudinalcohort study[J]. Lancet, 2001,357 (9271) : 1831-1836.
  • 9Del Mistro A,Frayle-Salamanca H, Trevisan R, et al. Tri-age of women with atypical squamous cells of undeter- mined significance (ASC-US) :Results of an Italian multi- centric study[J]. Gynecol Oncol, 2010,117(1) : 77-81.
  • 10Gyllensten U, Sanner K, Gustavsson I, et al. Short-time re- peat high-risk HPV testing by self-sampIing for screening of cervical cancer[J]. Br J Cancer, 2011,105(5) : 694-697.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部